S-3 EX-FILING FEES 0001677077 true false N/A 0001677077 1 2026-11-17 2026-11-17 0001677077 1 2026-11-17 2026-11-17 0001677077 2 2026-11-17 2026-11-17 0001677077 2026-11-17 2026-11-17 iso4217:USD xbrli:pure xbrli:shares

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Alzamend Neuro, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

                                           
    Security Type   Security Class Title   Note   Fee Calculation
Rule
  Amount Registered   Proposed Maximum Offering
Price Per Unit
  Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to Be Paid   Equity   Common stock, par value $0.0001 per share   (1)   Rule 457(a)   39,355,322   $ 1.2050   $ 47,423,163.01   0.000087   $ 4,125.82
                                           
Total Offering Amounts:   $ 47,423,163.01         4,125.82
Total Fees Previously Paid:                
Total Fee Offsets:               4,125.82
Net Fee Due:             $ 0.00
(1) (a) Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of common stock that become issuable upon conversion of the shares of Series D convertible preferred stock (the “Series D Preferred Shares”) issued or issuable by Alzamend Neuro, Inc. (the “Company”) to Ault Lending, LLC (the “Selling Stockholder”) pursuant to that certain amended and restated securities purchase agreement by and between the Company and the Selling Stockholder dated as of November 10, 2026 (the “Purchase Agreement”), by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of the Company’s common stock (“Common Stock”), as applicable.

(b) Represents shares of Common Stock issuable upon conversion of the Series D Preferred Shares to be sold by the Company to the Selling Stockholder pursuant to the Purchase Agreement.

(c) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the Common Stock, as reported on The Nasdaq Capital Market on November 16, 2026, which date is within five business days prior to the filing of this registration statement.

(d) The filing fee due for this Registration Statement is $4,125.82. In connection with the Registration Statement on Form S-1 (No. 333-298490) (the “Prior Registration Statement”) filed on August 21, 2026, the registrant paid a filing fee of $20,347.17 and, as described further below, such previously paid fee offsets the filing fee currently due pursuant to Rule 457(p) of the Securities Act. As a result, there is no net fee due for this Registration Statement.

Table 2: Fee Offset Claims and Sources

                                                         
    Registrant or Filer Name   Note   Form or Filing Type   File Number   Initial Filing Date   Filing Date   Fee Offset Claimed   Security Type Associated with Fee Offset Claimed   Security Title Associated with Fee Offset Claimed   Unsold Securities Associated with Fee Offset Claimed   Unsold Aggregate Offering Amount Associated with Fee Offset Claimed   Fee Paid with Fee Offset Source
                                                         
Rule 457(p)
Fee Offset Claims   Alzamend Neuro, Inc.    (1)   S-1   333-298490   08/21/2026       $ 4,125.82   Equity   Common stock, par value $0.0001 per share     98,388,305   $ 147,336,486.74   $  
Fee Offset Sources   Alzamend Neuro, Inc.        S-1   333-298490       08/21/2026                               $4,125.82
                                                         
(1) A filing fee of $20,347.17 was previously paid in connection with the Prior Registration Statement. The registrant withdrew the Prior Registration Statement by filing a Form RW on October 9, 2026. As the Prior Registration Statement was not declared effective, no securities were sold thereunder. Accordingly, pursuant to Rule 457(p), $20,347.17 is available to offset the fee currently due and additional fees that may be due for future registration statements. As the total filing fee required for this Registration Statement is $4,125.82, taking into consideration the available offset of $20,347.17 from the Prior Registration Statement, there is no net fee due for this Registration Statement.